These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8859940

  • 1. Cardioprotective effects of NIP-121, a novel ATP-sensitive potassium channel opener, during ischemia and reperfusion in coronary perfused guinea pig myocardium.
    Tanaka H, Okazaki K, Shigenobu K.
    J Cardiovasc Pharmacol; 1996 May; 27(5):695-701. PubMed ID: 8859940
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning.
    Shigematsu S, Sato T, Abe T, Saikawa T, Sakata T, Arita M.
    Circulation; 1995 Oct 15; 92(8):2266-75. PubMed ID: 7554211
    [Abstract] [Full Text] [Related]

  • 3. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage.
    Cole WC, McPherson CD, Sontag D.
    Circ Res; 1991 Sep 15; 69(3):571-81. PubMed ID: 1908354
    [Abstract] [Full Text] [Related]

  • 4. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation.
    McPherson CD, Pierce GN, Cole WC.
    Am J Physiol; 1993 Nov 15; 265(5 Pt 2):H1809-18. PubMed ID: 8238595
    [Abstract] [Full Text] [Related]

  • 5. K+ channel-opening properties of a novel compound, NIP-121, in guinea pig myocardium as compared with those of cromakalim.
    Matsuda T, Okazaki K, Kato Y, Tanaka H, Shigenobu K.
    J Cardiovasc Pharmacol; 1995 Oct 15; 26(4):608-13. PubMed ID: 8569223
    [Abstract] [Full Text] [Related]

  • 6. Class I antiarrhythmic drugs alter the severity of myocardial stunning by modulating ATP-sensitive K+ channels in guinea pig ventricular muscles.
    Shigematsu S, Sato T, Arita M.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar 15; 357(3):283-90. PubMed ID: 9550300
    [Abstract] [Full Text] [Related]

  • 7. Action potential shortening and negative inotropic effects of a novel potassium channel opener, NIP-121, as compared with cromakalim in guinea pig ventricular myocardium.
    Shigenobu K, Kageyama C, Watanabe M.
    Jpn J Pharmacol; 1991 Sep 15; 57(1):117-21. PubMed ID: 1800795
    [Abstract] [Full Text] [Related]

  • 8. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Tosaki A, Hellegouarch A.
    J Am Coll Cardiol; 1994 Feb 15; 23(2):487-96. PubMed ID: 8294705
    [Abstract] [Full Text] [Related]

  • 9. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
    Venkatesh N, Stuart JS, Lamp ST, Alexander LD, Weiss JN.
    Circ Res; 1992 Dec 15; 71(6):1324-33. PubMed ID: 1423930
    [Abstract] [Full Text] [Related]

  • 10. Cardioprotection without cardiosuppression by SEA0400, a novel inhibitor of Na+-Ca2+ exchanger, during ischemia and reperfusion in guinea-pig myocardium.
    Namekata I, Nakamura H, Shimada H, Tanaka H, Shigenobu K.
    Life Sci; 2005 Jun 03; 77(3):312-24. PubMed ID: 15878358
    [Abstract] [Full Text] [Related]

  • 11. Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration.
    Grover GJ, D'Alonzo AJ, Parham CS, Darbenzio RB.
    J Cardiovasc Pharmacol; 1995 Jul 03; 26(1):145-52. PubMed ID: 7564356
    [Abstract] [Full Text] [Related]

  • 12. JTV-519, a novel cardioprotective agent, improves the contractile recovery after ischaemia-reperfusion in coronary perfused guinea-pig ventricular muscles.
    Ito K, Shigematsu S, Sato T, Abe T, Li Y, Arita M.
    Br J Pharmacol; 2000 Jun 03; 130(4):767-76. PubMed ID: 10864882
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardioprotective effects of beraprost sodium against experimental ischemia and reperfusion as compared with propranolol and diltiazem.
    Tanaka H, Matsui S, Shigenobu K.
    Res Commun Mol Pathol Pharmacol; 1998 Mar 03; 99(3):321-7. PubMed ID: 9591326
    [Abstract] [Full Text] [Related]

  • 15. Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia. Role of oxygen radical-induced no-reflow phenomenon.
    Aiello EA, Jabr RI, Cole WC.
    Circ Res; 1995 Jul 03; 77(1):153-62. PubMed ID: 7788873
    [Abstract] [Full Text] [Related]

  • 16. Use of chloride blockers: a novel approach for cardioprotection against ischemia-reperfusion damage.
    Tanaka H, Matsui S, Kawanishi T, Shigenobu K.
    J Pharmacol Exp Ther; 1996 Aug 03; 278(2):854-61. PubMed ID: 8768740
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ATP-sensitive K+ channels in cardiac ischemia: an endogenous mechanism for protection of the heart.
    Cole WC.
    Cardiovasc Drugs Ther; 1993 Aug 03; 7 Suppl 3():527-37. PubMed ID: 8251423
    [Abstract] [Full Text] [Related]

  • 19. Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium.
    Pomerantz BJ, Robinson TN, Morrell TD, Heimbach JK, Banerjee A, Harken AH.
    J Thorac Cardiovasc Surg; 2000 Aug 03; 120(2):387-92. PubMed ID: 10917958
    [Abstract] [Full Text] [Related]

  • 20. Bepridil blunts the shortening of action potential duration caused by metabolic inhibition via blockade of ATP-sensitive K(+) channels and Na(+)-activated K(+) channels.
    Li Y, Sato T, Arita M.
    J Pharmacol Exp Ther; 1999 Nov 03; 291(2):562-8. PubMed ID: 10525072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.